English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Notch-mediated generation of monocyte-derived Langerhans cells : phenotype and function

MPS-Authors
/persons/resource/persons141943

Schulze,  Jessica
Christoph Rademacher, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons238083

Rentzsch,  Mareike
Christoph Rademacher, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121753

Rademacher,  Christoph
Christoph Rademacher, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)

Article.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Bellmann, L., Zelle-Rieser, C., Milne, P., Resteu, A., Tripp, C. H., Hermann-Kleiter, N., et al. (2021). Notch-mediated generation of monocyte-derived Langerhans cells: phenotype and function. Journal of Investigative Dermatology, 141(1), 84-94.e6. doi:10.1016/j.jid.2020.05.098.


Cite as: http://hdl.handle.net/21.11116/0000-0006-867A-A
Abstract
Langerhans cells (LCs) in the skin are a first line of defense against pathogens but also play an essential role in skin homeostasis. Their exclusive expression of the C-type lectin receptor Langerin/CD207 makes them prominent candidates for immunotherapy. For vaccine testing, an easily accessible cell platform would be desirable as an alternative to the time-consuming purification of LCs from human skin. Here we present such a model and demonstrate that monocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), transforming growth factor (TGF)-β1 and the Notch ligand Delta-like 4 (DLL4) differentiate within 3 days into CD1a+Langerin+cells containing Birbeck granules. RNA-sequencing (RNA-seq) of these monocyte-derived LCs (moLCs) confirmed gene expression of LC-related molecules, pattern recognition receptors and enhanced expression of the antigen-presenting machinery. On protein level, moLCs showed low expression of costimulatory molecules but prominent expression of C-type lectin receptors. MoLCs can be matured, secrete IL-12p70 and TNF-α and stimulate proliferation and cytokine production in allogeneic CD4+ and CD8+ T cells. In regard to vaccine testing, a recently characterized glycomimetic Langerin ligand conjugated to liposomes demonstrated specific and fast internalization into moLCs. Hence, these short-term in vitro-generated moLCs represent an interesting tool to screen LC-based vaccines in the future.